Introducing the Zensor™ device, a new solution to detect and analyse Atrial Fibrillation for up to 14 days

Find out how Cardiologists are improving the detection of Atrial Fibrillation.


The rising costs of detecting Atrial Fibrillation

Atrial Fibrillation (AF) is the most common type of arrhythmia and is a major risk factor for stroke, contributing to 1 in 5 strokes. It is estimated that in the UK alone, 1.4 million people have AF but almost 500,000 cases go undetected as symptoms are often difficult to detect.

However, with detection and appropriate treatment, the risk of stroke can be substantially reduced.


What is the Zensor™ device?

The Zensor™ device allows you to measure, analyse and report a patient’s heart rhythm for up to 14 days.

The only 3-lead continuous ECG and Wi-Fi enabled event monitor ensures optimal beat-by-beat trace clarity and can provide critical insight, particularly for paroxysmal atrial fibrillation, bradycardia and tachycardia detection.

With Zensor+ TM software, a comprehensive full disclosure report can be generated ready for analysis, review and consultation.


What are the key benefits of the Zensor™ device?

Three-lead ECG provides enhanced cardiac visualisation

Continuous onboard recording for up to 14 days

Electrodes designed to minimise motion artefacts for improved data clarity

Patient-friendly device which is comfortable to wear results in high patient compliance

Wi-Fi enabled event detection

Direct access to full diagnostic ECG and event data reports through Zensor™ device software

Assured Data Clarity

The Zensor™ device is used with specifically designed motion artefact-reducing electrodes that optimise signal clarity. The patented electrodes overcome one of the key clinical challenges with traditional ECG and vital signs monitors – motion artefact.

The Zensor™ device has demonstrated an impressive >95% sensitivity for AF detection.

Benefits to you and your team

  • Improve patient outcomes through reliable AF detection and other arrhythmias
  • High patient compliance
  • Combined ECG and Event data recorded for up to 14 days
  • Full disclosure data reporting through Zensor+™ Analysis Software
  • Off-site ECG assessment reporting service available

Benefits to your patients

  • Simple to use, non-invasive device, that supports up to 14 day continuous wear
  • Compact device with water-resistant electrodes ensures minimal impact on patient lifestyle
  • Patient data is private and secure

4-step streamlined workflow:

Step 1

Zensor™ device assigned, attached to patient and activated

Step 2

Optional Wi-Fi enabled event notification

Step 3

Once the device is returned, patient data is uploaded direct to Zensor+™ Software

Step 4

Access to high-quality, full disclosure ECG data and summary report



Request a demonstration

Please select your title

Please enter your first name

Please enter your last name

Please enter your hospital / organisation name*

Please enter your job title*

Please enter your email address

Please enter your mobile number. Landlines are not accepted

Please enter a valid landline telephone number. Mobiles are not accepted.

Please include your phone number and one of our team will contact you to discuss your requirements.

Please choose one of the options shown. You must opt-in to at least one contact option.

Would you like us to email you the Zensor brochure and further details

Please choose one of the options shown. You must opt-in to at least one contact option.

By clicking SUBMIT you agree to our privacy policy.